Labiotech.eu

Interview 24 Jul 2018

Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”

Known for curing US President Jimmy Carter’s cancer, Keytruda continues to benefit many other cancer patients. The inventors told us their story, from the drug’s early days to their current role as executives of the biotech unicorn Aduro. Since 2014, the cancer drug Keytruda, also known as pembrolizumab, continues to be widely sought after due […]

July 24, 2018 - 6 minutesmins - By Editorial Team

News and Trends 23 Jul 2018

UK Biotech to Launch Rapid, Accurate HIV Test in Europe

UK-biotech Owen Mumford plans to launch an HIV diagnostic test in Europe that can produce an accurate result within 15 minutes. Current rapid diagnostic tests for HIV can lead to misdiagnosis, for example when steps in the procedure are not followed in the right order, or too little blood is drawn. The new test, called […]

July 23, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 23 Jul 2018

Sangamo Acquires French Biotech to Develop CAR-T Therapies for Autoimmune Disease

Sangamo Therapeutics has acquired TxCell with a view to utilizing its CAR-T technology to prevent organ transplant rejections and treat autoimmune disease. Sangamo, based in California, is known for bringing the first in-vivo gene therapy to the market. The company entered into an agreement to purchase TxCell for €72M. Sangamo plans to combine its zinc […]

July 23, 2018 - 3 minutesmins - By Alexander Burik

Somewhere in Between Wellcome Collection 1

News and Trends 21 Jul 2018

Somewhere in Between: Exploring Art and Science Collaborations

The latest art and science exhibition at the Wellcome Collection, Somewhere in Between, explores ideas about cattle farming, multisensory synaesthesia, sexual health and virus transmission, and the human capacity to breathe. In an unprecedented level of collaboration, the exhibition is comprised of four art-science projects stemming from projects funded by the Wellcome Trust with the […]

July 21, 2018 - 4 minutesmins - By External Contributor

News and Trends 20 Jul 2018

Belgian Biotech Completes First Trial with New Drug for Diabetic Macular Edema

Belgian biotech ThromboGenics has conducted the first clinical trial of an antibody to treat one of the world’s leading causes of vision loss. Results from the Phase I/II trial demonstrate the safety and tolerability of a new kind of antibody treatment for diabetic macular edema. The trial focused on injecting the THR-317 antibody, which is directed against […]

July 20, 2018 - 2 minutesmins - By External Contributor

News and Trends 20 Jul 2018

German Private Equity Firm Raises €90M for Life Sciences and Medtech

SHS has raised €90M in the first closing of its fifth fund dedicated to companies in life sciences and medtech. SHS, based in Tübingen, is aiming to raise a total of €150M for its fifth fund. In this first closing, around half of the €90M raised came from existing investors including professional pension insurers and family […]

July 20, 2018 - 1 minutemin - By Alexander Burik

News and Trends 19 Jul 2018

Kite Partners with Dutch Biotech to Develop a New Form of CAR-T Therapy

Kite will support Gadeta in the development of a new type of CAR-T therapy that could be more effective in solid tumors. Approved just last year, CAR-T cell therapy is offering hope to patients with severe forms of blood cancer. The developer of one of only two CAR-T therapies currently in the market, Kite, has […]

July 19, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

More News! 18 Jul 2018

Lab-Grown Meat Will Be on the Market in 2021

Dutch startup Mosa Meat has raised €7.5M in a Series A round, which will support the development of a first lab-grown meat product that is expected to make it to market by 2021. Mosa Meat is a Dutch startup co-founded by Mark Post, the scientist behind the world’s first lab-grown burger. After an early investment […]

July 18, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 17 Jul 2018

Gene Therapy Could Prevent Deadly Brain Disease

An international research team used gene therapy to prevent Gaucher disease, a potentially deadly neurodegenerative condition, in mice. The approach could eventually be used to treat human diseases in the womb. A research team from the UK and Singapore showed that a neurodegenerative condition called Gaucher disease, which can be fatal, can be prevented in […]

July 17, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 16 Jul 2018

CRISPR-Cas9 Shown to Cause Previously Unseen DNA Damage

Researchers at the Wellcome Trust Sanger Institute in the UK have found that gene editing with CRISPR-Cas9 can cause significantly more off-target damage to the DNA than previously thought. Published today in Nature Biotechnology, the study is the first to look at unexpected DNA changes caused by CRISPR across large regions of the genome. […]

July 16, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Sickle Cell Disease Modus Therapeutics Cover

News and Trends 16 Jul 2018

Series A Boost for Swedish Biotech’s Sickle Cell Disease Treatment

Modus Therapeutics closed SEK 140M (€13.5M) in Series A financing to complete a Phase II study testing its sickle cell disease drug and to prepare for further clinical trials. The financing round was led by HealthCap, a European venture capital firm focused on life science investments, which will contribute SEK 60M (€5.8M). The remaining funds […]

July 16, 2018 - 3 minutesmins - By Alexander Burik

Flow State Francis Crick Institute Alex May

More News! 14 Jul 2018

An Artist’s Insight into the Day-to-Day Life at the Francis Crick Institute

A new interactive art installation at the Francis Crick Institute in London lets visitors peek into what life at the famous research institute is like. “The Francis Crick Institute is this incredible, huge, imposing building of which the public can see very little inside,” Alex May, a British digital artist, told me during an interview. His […]

July 14, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”

UK Biotech to Launch Rapid, Accurate HIV Test in Europe

Sangamo Acquires French Biotech to Develop CAR-T Therapies for Autoimmune Disease

Somewhere in Between: Exploring Art and Science Collaborations

Belgian Biotech Completes First Trial with New Drug for Diabetic Macular Edema

German Private Equity Firm Raises €90M for Life Sciences and Medtech

Kite Partners with Dutch Biotech to Develop a New Form of CAR-T Therapy

Lab-Grown Meat Will Be on the Market in 2021

Gene Therapy Could Prevent Deadly Brain Disease

CRISPR-Cas9 Shown to Cause Previously Unseen DNA Damage

Series A Boost for Swedish Biotech’s Sickle Cell Disease Treatment

An Artist’s Insight into the Day-to-Day Life at the Francis Crick Institute

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!